Physician CME

As the U.S. population ages, family physicians play an increasingly important role in caring for older adults with complex and often interrelated health needs. Developed by the American Academy of Family Physicians (AAFP)—the nation’s leading professional association dedicated to family medicine—this comprehensive CME course, Geriatric Medicine On Demand, provides practical, evidence-based education to help physicians confidently diagnose, manage, and support aging patients and their families.

Designed for family physicians and other primary care clinicians, the course explores key geriatric topics including cholesterol management, diabetes, depression, Alzheimer’s disease, and other common conditions affecting older adults. Participants will gain clinically relevant knowledge that can be applied immediately in practice to enhance decision-making, improve patient outcomes, and deliver compassionate, patient-centered care. This activity is approved for up to 21.75 Enduring Materials, Self-Study AAFP Prescribed credits.

Accurate ECG interpretation is essential for identifying cardiac conditions ranging from common rhythm abnormalities to potentially life-threatening events. Developed by the American Academy of Family Physicians (AAFP)—the leading professional association serving family physicians—this evidence-based CME course, ECG Interpretation On Demand, helps clinicians strengthen their ECG interpretation skills through practical, clinically relevant education designed for primary care practice.

Using a systematic approach, participants will build confidence in recognizing normal and abnormal ECG findings, identifying subtle high-risk patterns, and applying ECG results to patient care decisions. Ideal for family physicians and other primary care professionals, this flexible online course helps address knowledge gaps and enhance diagnostic proficiency in a convenient, self-paced format. This activity is approved for up to 12.25 Enduring Materials, Self-Study AAFP Prescribed credits.

The Venetian Resort Las Vegas | Las Vegas, NV

The Venetian Resort Las Vegas | Las Vegas, NV
Western Mediterranean: Aboard Sun Princess

“Women reaching the average age of menopause today were not yet 30 when the Women’s Health Initiative (WHI) reshaped care in 2002. At that time, perimenopause was largely unrecognized, and even today, training in midlife women’s health across nursing, medical school, and residency remains insufficient.

This comprehensive course provides state of the art, evidence based education on the care of women in perimenopause, menopause, and beyond. Sessions are designed to deliver practical clinical insights, actionable strategies, and real world pearls for daily practice.

Key topics include hot flashes and night sweats, sleep disturbance, hormone therapy risks and benefits (including testosterone), weight gain/obesity and osteoporosis management, mood and cognitive changes, low libido and sexual dysfunction, vaginal dryness and dyspareunia, and nonhormonal treatment options for all of these.

Lectures and interactive Q&A sessions are led by a multidisciplinary faculty of recognized experts in gynecology, primary care, breast health, psychiatry, dermatology, obesity medicine, sexual medicine, neurology, physical therapy, and nursing.

Attendees will leave with immediately applicable knowledge to improve patient outcomes in midlife women’s health. We look forward to welcoming you to an exceptional educational experience in Washington, DC.”

Program Directors- Drs. Steve Goldstein and James Simon

The integration into practice of sustained delivery devices and therapies that offer longer duration of action have further revolutionized the management of patients with diabetic macular edema (DME). However, selecting patients who will optimally benefit from these newer therapies can be challenging. Biomarkers of vascular instability are emerging, which could help guide treatment decisions and provide useful tools for monitoring disease control. This CE activity utilizes Curbside Consults, a dynamic and interactive case-based platform that will highlight these therapeutic strategies for the management of DME that reduce dosing frequency and enhance anatomic outcomes. Experts in the field also review the role of novel biomarkers to guide early clinical decision-making and evaluate treatment options for patients with DME based on the latest clinical evidence.

Despite major therapeutic advances, diabetic macular edema (DME) remains a leading cause of vision loss in adults with diabetes, with delayed diagnosis, treatment burden, and suboptimal responses continuing to challenge real-world outcomes. Although intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the established first-line standard of care, many patients experience persistent or refractory DME, and long-term visual gains in routine practice often fall short of results seen in clinical trials due to undertreatment and adherence challenges. Early identification of inadequate treatment response and timely therapy modification are critical, as untreated or insufficiently treated DME can result in significant, irreversible vision loss. Emerging evidence supports the use of newer anti-VEGF agents with extended dosing intervals, as well as the early integration of corticosteroid implants for patients with suboptimal responses. Corticosteroid therapies offer broad anti-inflammatory benefits and have demonstrated meaningful visual and anatomical improvements, particularly when introduced earlier in the disease course. In this CE Snips activity, expert faculty assess how to recognize when patients with DME demonstrate insufficient response to anti-VEGF therapy and when to integrate corticosteroid therapy based on current clinical evidence and real-world data.

Welcome to Colorado and Contemporary OB-GYN Ultrasound 2026: Advances in Maternal-Fetal Imaging. We are pleased to welcome you back to our live, high-quality, evidence-based education. This hybrid program offers comprehensive education in prenatal and gynecologic ultrasound, led by experts in maternal-fetal medicine, gynecology, and radiology. Using a multidisciplinary approach, the course addresses complex obstetric conditions, including fetal malformations, placental disorders, growth abnormalities, and complicated twin pregnancies, as well as common and uncommon gynecologic imaging challenges. Designed for both novice and experienced learners, the program emphasizes practical, clinically relevant updates to support diagnostic confidence and patient care.

Nuclear Medicine and Molecular Imaging in Modern Practice features an expert faculty discussing the evolution of radiopharmaceuticals, administration equipment and imaging tools. Created from the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 54th Annual Conference, this activity details nuclear medicine’s impact on cardiology, imaging, oncology and much more. A focused analysis and update regarding theranostics is provided, as well. Worth 15 AMA PRA Category I Credits™, Nuclear Medicine and Molecular Imaging in Modern meets Nuclear Medicine/PET accreditation requirements and provides an essential update for all physicians and technologists involved with this area of medicine.

Type 2 diabetes (T2D) rarely travels alone. Most patients carry overlapping cardiovascular, renal, and metabolic (CKM) risk, and this convergence is now central to how T2D should be managed, not a comorbidity footnote. Despite clear guideline recommendations, GLP-1 RAs and dual GIP/GLP-1 RAs with proven cardiovascular and renal benefit remain underused among patients who stand to gain the most. Patient complexity, an expanding evidence base for outcomes, and persistent clinical inertia all contribute to this gap.

Endocrinologists, endocrinology NPs and PAs, and the broader care team are positioned to close it. This training program, modeled on the CDC Training of Trainers approach, equips endocrinology-led teams to build CKM risk into everyday T2D decision-making: selecting and sequencing GLP-1-based therapies according to a patient’s cardiovascular, renal, and metabolic profile, not glycemic control alone. The content also addresses related benefits emerging in this drug class, including MASH and OSA, within the broader CKM framework.Designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025
Expert thought leaders provide insights to help clinicians apply these findings to their management of patients with nAMD, DME, and RVO when using newer therapies that support longer treatment intervals.

Bronchiectasis is a complex and increasingly prevalent condition often overlooked in clinical practice, with frequent overlap with other respiratory diseases such as COPD and asthma. Persistent airway inflammation, chronic infection, and mucociliary dysfunction drive disease progression, leading to significant morbidity and healthcare burden. As the clinical burden of bronchiectasis becomes increasingly recognized, there is an urgent need to better understand the underlying mechanisms of neutrophilic inflammation, alongside efforts to improve early diagnosis and explore current and emerging treatment options that target this vicious cycle.

In this activity, a panel of leading pulmonologists tackle the evolving challenges and emerging opportunities in bronchiectasis management. From diagnostic workup to airway clearance and exacerbation control, the discussion will blend expert insight with real-world clinical scenarios and patient perspectives.
Endocrinologists, endocrinology NPs and PAs, and the broader care team are positioned to close it. This training program, modeled on the CDC Training of Trainers approach, equips endocrinology-led teams to build CKM risk into everyday T2D decision-making: selecting and sequencing GLP-1-based therapies according to a patient’s cardiovascular, renal, and metabolic profile, not glycemic control alone. The content also addresses related benefits emerging in this drug class, including MASH and OSA, within the broader CKM framework.Designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025
Expert thought leaders provide insights to help clinicians apply these findings to their management of patients with nAMD, DME, and RVO when using newer therapies that support longer treatment intervals.

Join us for the Outpatient Medicine Update, a live, in-person, CME conference designed for today’s practicing clinicians. Sessions are led by experienced physicians and optimized for primary care, internal medicine, and outpatient practice. This course is tailored for physicians, nurse practitioners, physician assistants, and pharmacists. Earn 16 accredited CME credits (ACCME, ANCC, ACPE, AAFP, AOA, ABIM) while enjoying a working vacation.

Why Attend?
• LIVE classes taught by practicing physicians.
• Course schedule – Wednesday to Saturday, 7:30-11:30 a.m.
• Live streaming available.
• Afternoons free to enjoy the rest of your day to explore and unwind.
• 3-month access to Outpatient Medicine Update On Demand ($695 value with up to 16 additional credits).

Join us for the Outpatient Medicine Update, a live, in-person, CME conference designed for today’s practicing clinicians. Sessions are led by experienced physicians and optimized for primary care, internal medicine, and outpatient practice. This course is tailored for physicians, nurse practitioners, physician assistants, and pharmacists. Earn 16 accredited CME credits (ACCME, ANCC, ACPE, AAFP, AOA, ABIM) while enjoying a working vacation.

Why Attend?
• LIVE classes taught by practicing physicians.
• Course schedule – Wednesday to Saturday, 7:30-11:30 a.m.
• Live streaming available.
• Afternoons free to enjoy the rest of your day to explore and unwind.
• 3-month access to Outpatient Medicine Update On Demand ($695 value with up to 16 additional credits).

This webcast focuses on the role of wearable devices in the timely identification of atrial fibrillation (AF) and the evolving evidence around the rationale for and efficacy/safety of early rhythm control strategies, including guideline recommendations and expert insights on the use of antiarrhythmic drugs (AADs) and catheter ablation. It also incorporates an AI-powered patient simulator as a method by which participants can practice how they engage patients in shared decision-making discussions regarding rhythm control strategies

This educational activity reviews emerging clinical evidence and evolving treatment strategies for transthyretin amyloid cardiomyopathy (ATTR-CM), with a focus on recently approved disease-modifying therapies. Learners will examine key clinical trial data related to efficacy, safety, quality of life, functional outcomes, and long-term disease stabilization, as well as explore how these findings may be applied in patient scenarios representative of contemporary clinical practice.

Hear from a panel of clinicians from community practices about their experiences, including the challenges and successes, with integrating B-cell maturation antigen (BCMA)-directed bispecific antibodies into their practices. Explore patient management strategies for bispecific antibodies, from starting treatment at a community center to providing long-term care after treatment initiation at either a community or tertiary center.

This CME activity reviews the efficacy and safety of available B-cell maturation antigen (BCMA)-directed bispecific antibodies for multiple myeloma and explores the latest clinical data on their use in earlier lines of therapy and in emerging combination regimens.